Fortis Life Sciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
223
- Latest Deal Type
-
Debt - Acquisition
- Latest Deal Amount
-
$210M
- Investors
-
1
Fortis Life Sciences General Information
Description
Provider of contract development and manufacturing services and life sciences tools intended to support research, diagnostic, and biopharma companies. The company offers custom antibodies, recombinant proteins, assays, and related development and manufacturing services, enabling researchers and diagnostic manufacturers to accelerate scientific and product development.
Contact Information
Website
www.fortislife.comCorporate Office
- 7 Whittier Place
- Suite 108 PMB 173
- Boston, MA 02114
- United States
Corporate Office
- 7 Whittier Place
- Suite 108 PMB 173
- Boston, MA 02114
- United States
Fortis Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Debt - Acquisition | 17-Sep-2021 | $210M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Jan-2020 | Completed | Startup |
Fortis Life Sciences Patents
Fortis Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240044920-A1 | Anti-ceruloplasmin antibodies and uses thereof | Active | 11-Sep-2020 |
Fortis Life Sciences Signals
Fortis Life Sciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Summit Partners | PE/Buyout | Minority |
Fortis Life Sciences Acquisitions (6)
Fortis Life Sciences’s most recent deal was a Merger/Acquisition with International Point of Care. The deal was made on 12-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| International Point of Care | 12-Jul-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Abcore | 02-Mar-2022 | Merger/Acquisition | Biotechnology | ||
| Arista Biologicals | 16-Feb-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Empirical Bioscience | 17-Sep-2021 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| nanoComposix | 23-Jul-2021 | Merger/Acquisition | Commodity Chemicals |
Fortis Life Sciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| nanoComposix | San Diego, CA | 2004 | |
| Arista Biologicals | Coopersburg, PA | 1993 |
Fortis Life Sciences FAQs
-
When was Fortis Life Sciences founded?
Fortis Life Sciences was founded in 2020.
-
Where is Fortis Life Sciences headquartered?
Fortis Life Sciences is headquartered in Boston, MA.
-
What is the size of Fortis Life Sciences?
Fortis Life Sciences has 223 total employees.
-
What industry is Fortis Life Sciences in?
Fortis Life Sciences’s primary industry is Discovery Tools (Healthcare).
-
Is Fortis Life Sciences a private or public company?
Fortis Life Sciences is a Private company.
-
What is Fortis Life Sciences’s current revenue?
The current revenue for Fortis Life Sciences is .
-
How much funding has Fortis Life Sciences raised over time?
Fortis Life Sciences has raised $210M.
-
Who are Fortis Life Sciences’s investors?
Summit Partners has invested in Fortis Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process